ANI Pharmaceuticals, Inc.
$73.50
$1.39 (+1.93%)
$72.21Day Range$73.69
Key Statistics
Market Cap
$1.66B
Shares Outstanding
23.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 13, 1999
Round Lot
100
Locale
US
Trading Data
Day Open
$72.21
Day High
$73.69
Day Low
$72.21
Volume
201.9K
VWAP
$72.96
Prev Close
$72.11
Transactions
--
Acc. Volume
--
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
PHARMACEUTICAL PREPARATIONSSIC 2834970 employees104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540(609) 759-1810IPO Sep 13, 1999US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001023024
- Composite FIGI
- BBG000KK1L04
- Share Class FIGI
- BBG001S9DR85
- Ticker Root
- ANIP
- SIC Code
- 2834
About ANI Pharmaceuticals, Inc. (ANIP) Stock
ANI Pharmaceuticals, Inc. (ANIP) closed the 2026-09-16 session at $73.50, up 1.93% versus the previous close (+1.39). The stock opened at $72.21 and traded between $72.21 and $73.69 during that session. Session trading volume was 202K shares. The volume-weighted average price (VWAP) is $72.96.
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
ANI Pharmaceuticals, Inc. has a market capitalization of $1.66 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ANIP is listed on the XNAS exchange. The company employs approximately 970 people. ANI Pharmaceuticals, Inc. is headquartered in PRINCETON, NJ. The recorded listing date is 1999-09-13.
On this page you can find market ANIP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.